Speakers

Sandrine Andrieu, MD, PhD, is physician and professor of public health, chair of the clinical  epidemiology and public health department at the Toulouse University Hospital and adjunct professor at the University New Mexico (USA).Since 2009, she has been director of the aging research team in the Center for Epidemiology and Research in Population Health (CERPOP, UMR1295 Inserm – Toulouse University). She served as Director of the Research Center for Epidemiology and Research in Population Health (UMR1027 Inserm – Toulouse University) from 2011 to 2020. She has published more than 300 international papers and book chapters in the field of aging and Alzheimer’s disease. She was involved in large prevention studies in the field of neuro-degenerative disease (GuidAge, MAPT) and in European projects (HATICE study, MIND-AD, PRODEMOS study). Her main topic of research is Alzheimer’s disease and prevention of age-related loss of functions, and healthy aging. She is past-president of the French National Society of Geriatrics and Gerontology and past-president of the scientific committee of the French Alzheimer Association.

Manish Arora, BDS, MPH, PhD, is the Edith J. Baerwald Professor and Vice Chairman of Environmental Medicine at the Icahn School of Medicine at Mount Sinai, and Co-Founder and CEO of LinusBio. An environmental epidemiologist and exposure biologist, he directs Mount Sinai’s precision environmental medicine labs and co-founded the Institute for Exposomic Research. His work focuses on how prenatal and early-life exposures influence long-term health, including autism, ALS, cancer, and GI disorders.

Dr. Arora developed the “Biodynamic Interface Theory,” a framework explaining how environmental exposures interact with physiology over time. He pioneered the use of teeth and hair as biomarkers to map early-life exposures, leading to an FDA Breakthrough Designation for an autism biomarker. He is principal investigator on several NIH-funded studies and has received numerous honors, including the PECASE award from President Obama and the NIH Director’s New Innovator Award. His book Environmental Biodynamics was published by Oxford in 2021.

David Balshaw, PhD, is the Director of the Division of Extramural Research and Training at the National Institute of Environmental Health Sciences (NIEHS). Dr. Balshaw is a biophysicist by training with a PhD from the Department of Pharmacology and Cellular Biophysics at the University of Cincinnati and post-doctoral training in the Department of Biochemistry and Biophysics at the University of North Carolina. He joined NIH as a Program Officer at the National Heart, Lung, and Blood Institute in 2001 and moved to NIEHS in 2003. Over nearly two decades he has led several high impact programs at NIEHS and NIH particularly in the areas of ‘omics technologies and is an international leader in the field of exposomics.

With the participation and concurrence of senior leadership of NIEHS, the Division of Extramural Research and Training (DERT) develops program priorities to assure maximum utilization of available resources in attainment of the objectives stated in the NIEHS Strategic Plan. By collaborating with other institutes at NIH, other federal agencies, and public and private institutions and organizations, DERT staff maintain an awareness of national and international research efforts and priorities, and identify new opportunities for collaborative research and training initiatives involving the environmental health sciences.

Robert Barouki, MD, PhD, is a University Professor and Hospital Practitioner, seconded to the French National Institute of Public Health and Medical Research (INSERM) to head both the INSERM Public Health Thematic Institute and French Institute for Public Health Research. His recent research focuses on the toxicity mechanisms of environmental pollutants such as dioxins, pesticides, and endocrine disruptors, as well as the effects of toxic mixtures. Dr. Barouki has been interested in the concept of the exposome for many years and in multidisciplinary and integrated approaches in the environment/health field. He coordinates or participates in several European programs. More broadly, he is keenly interested in communicating scientific concepts and data to the general public. He was awarded the 2018 OPECST-INSERM Prize and is a full member of the French National Academy of Medicine.

Dinesh Barupal, PhD, is an Associate Professor in the Department of Environmental Medicine at the Icahn School of Medicine at Mount Sinai. Since 2020, He is leading the Integrated Data Science Laboratory for Metabolomics and Exposomics (IDSL.ME). His research focuses on understanding exposome-induced metabolic dys-regulations and their relationships with chronic diseases. His group develops and implements novel computational methods for large-scale metabolomics and exposomics studies with a specialization in metabolic epidemiology, computational metabolomics, metabolic bioinformatics, biomedical text mining and the blood exposome. Dr Barupal is a leading computational biologist and exposure data scientist and over the past decade has developed several bioinformatics methods, including ChemRICH, MetaMapp, IDSL.GOA , the Blood Exposome Database  and the Exposome Correlation and Interpretation Database (ECID) to process and interpret metabolomics and exposomics datasets in the context of human metabolic biochemistry and exposure biology. Dr Barupal received his Doctoral and Post-Doctoral training at the University of California, Davis with Prof. Oliver Fiehn. He was a senior scientist in metabolomics and bioinformatics at the International Agency for Research on Cancer (IARC), World Health Organization in Lyon, France (2012-2015) and the West Coast Metabolomics Center, UC Davis (2016-2020). 

Marc Chadeau-Hyam, PhD, is Professor of Computational Epidemiology and Biostatistics within the School of Public Health, Faculty of Medicine at Imperial College London. His current research focuses on the analysis and integration of OMICs markers in relation to complex exposures and health outcomes. This work aims to characterize the molecular signatures of the exposome—encompassing both environmental exposures and social factors—while exploring the underlying mechanisms that mediate these effects.

Professor Chadeau-Hyam holds an engineering degree in food sciences, with a major in statistics, from the French grande école ONIRIS (formerly ENITIAA, part of the ‘Agro group’). He earned his PhD in statistics from the University Paris XI in 2005, where his research focused on modeling the French variant Creutzfeldt-Jakob disease epidemic. Following graduation, he was awarded a personal grant to join the London School of Hygiene and Tropical Medicine.

Later in 2005, he joined Imperial College London as a Research Associate, subsequently becoming a Research Fellow in Professor Paolo Vineis’s group in 2009. He was promoted to Lecturer in 2011, and to Senior Lecturer in Statistical Bioinformatics within the Department of Epidemiology and Biostatistics in 2016. Expanding his international collaborations, he was also awarded an Honorary Reader position at the Institute for Risk Assessment Sciences at Utrecht University (NL) in 2013.

While his foundational background lies in disease modeling, his post-doctoral experience has centered on developing and applying statistical models to analyze complex OMICs data. Through his leadership and involvement in several large-scale projects, he has established extensive expertise in analyzing genetic, epigenetic, transcriptomic, proteomic, and metabolomic profiles. Alongside this project-based portfolio, he maintains an active methodological research program dedicated to developing longitudinal models that track the risk and progression of chronic diseases.

Arthur David, PhD is Professor at the French School of Public Health, Research Institute for Environmental and Occupational Health (Irset) in Rennes, France. He is a researcher specializing in chemical exposomics, with a focus on understanding how environmental chemical exposures influence human health across the lifespan. His work integrates advanced analytical methods based on high-resolution mass spectrometry and computational methods to identify complex exposures, understand exposure–disease relationships, and support public-health decision-making.

Carole Dufouil, PhD, an epidemiologist and biostatistician, is research director at INSERM, Bordeaux Population Health Center and co-director of the VINTAGE team (Vascular and Neurological diseases: INTegrative and GEnetic epidemiology). Her research focuses on determinants of neurological diseases, especially Alzheimer’s disease. She is particularly interested in the role of vascular risk factor exposure and cognitively stimulating activities, and in imaging markers (Positron Emission Tomography and Magnetic Resonance Imaging) of brain aging and disease. She is also interested in the methodological challenges related to the analysis of studies on determinants of brain health and has created the international MELODEM initiative, which aims at harmonizing analytical approaches in longitudinal studies on dementia. Dr. Dufouil is co-PI of the 3C-Dijon study and co-PI of the MEMENTO study, a national clinical cohort, which was set up in the context of the Alzheimer Plan 2008-2013 and aims at improving our understanding of the natural course of Alzheimer’s disease.  She has published over 170 articles in international journals (H-index WOS: 55) and is a member of the editorial board of Alzheimer’s and Dementia: translational research & clinical interventions.

Fanny Elahi, MD, PhD is a physician-scientist at the Icahn School of Medicine at Mount Sinai, with joint appointments in Neurology and Neuroscience, and secondary appointment in the department of Artificial Intelligence and Human Health. She serves as Director of the Glickenhaus Center for Successful Aging, and is a leader at the NIA-funded Mount Sinai Alzheimer’s Disease Research Center (ADRC), where she co-directs the Biomarkers and Genetics Core and oversees the development of novel blood-based biomarkers for neurodegenerative diseases.

Dr. Elahi’s research bridges molecular and clinical phenotyping to accelerate therapeutic innovations in dementia, with particular emphasis on genetic vascular drivers of disease. Her multidisciplinary program integrates molecular techniques, clinical data, and computational methods to investigate the link between the aging and dysfunction of vasculature with neurodegeneration. A central goal of her work is to develop accessible blood biomarkers and leverage them to uncover disease mechanisms, stratify risk, and identify actionable therapeutic targets.

Dr. Elahi has authored over 80 peer-reviewed publications in leading scientific journals. She previously served as Chair of the Vascular Cognitive Disorders Professional Interest Area of ISTAART, where she led a global network of more than 800 investigators and played a central role in multiple NINDS-funded consortia advancing biomarker development and mechanistic understanding of vascular cognitive impairment and white matter disorders. She currently leads a patient-centered translational program aimed at defining immunovascular mechanisms of cognitive impairment and dementia, supported by DataPhilanthropy and the Chan Zuckerberg Initiative. She also directs the Davos Alzheimer’s Collaborative Healthcare System Preparedness and Accurate Diagnosis program at Mount Sinai and oversees multiple NIH-supported projects, as well as initiatives funded by the Rainwater Charitable Foundation and Rockefeller Philanthropy Advisors. Learn more about Dr. Elahi and her work at elahilab.com.

Alexis Elbaz, MD, PhD is a movement disorders neurologist and an epidemiologist specializing in neuro-epidemiology. He is a research professor at INSERM, where he is a co-leader of the Exposome and Heredity team at the Centre for Research in Epidemiology and Population Health in Villejuif. He is scientific co-director of the E3N-Generations cohort study, a transgenerational cohort of approximately 100,000 women recruited in 1990 and followed since then, more than 20,000 of their children, and nearly 20,000 fathers of their children.

A primary focus of his research is the epidemiology of Parkinson’s disease. He has coordinated several large-scale studies on Parkinson’s disease, focusing on environmental exposures and their interaction with genetic/epigenetic factors. He is a member of the steering committee of the Geo-PD and Courage-PD consortia and co-investigator of the EPIC consortium. Additionally, he is interested in the determinants and consequences of decline of motor performances during aging.

Thomas Hartung, MD PhD, holds multiple prestigious academic appointments across the globe. At Johns Hopkins University, he serves as a professor within the Bloomberg School of Public Health (Environmental Health & Engineering; Molecular Microbiology and Immunology), the Whiting School of Engineering, and the School of Medicine (Cellular and Molecular Medicine). Additionally, he holds professorships in Environmental Metrology and Policy at Georgetown University and in Pharmacology and Toxicology at the University of Konstanz, Germany.

Dr. Hartung is the Director of the Centers for Alternatives to Animal Testing (CAAT) in both the US and Europe and serves as the Field Chief Editor for Frontiers in AI. He has authored more than 760 scientific publications with over 56,000 citations (h-index 128). He authored 760+ scientific publications with 56,000+ citations (h-index 128) and his COURSERA toxicology classes had 23,000+ active learners.

Mike He, PhD, is an Instructor in the Department of Environmental Medicine at the Icahn School of Medicine at Mount Sinai, where he also completed his postdoctoral training. His research focuses on the health effects of air pollution in low- and middle-income countries, the use of satellite data for air pollution and health studies, and quantifying the impacts of extreme weather on air quality. More recently, he has worked on air pollution exposure modeling using machine-learning approaches and on investigating the effects of environmental mixtures on immune function. He earned his PhD in Environmental Health Sciences from Columbia University’s Mailman School of Public Health.

Itai Kloog, PhD, is an exposure scientist and geographic information system (GIS) specialist, with expertise in exposure assessment, environmental epidemiology, and geo-statistical modeling.  He holds a faculty appointment in the Department of Environmental Medicine at the Icahn School of Medicine at Mount Sinai. His research interests include developing exposure models, geo-statistical analysis, GIS and remote sensing, and evaluation of adverse health effects of exposure to air pollution and temperature extremes. He has published multiple articles in recent years on assessing spatio-temporally resolved PM2.5 and air temperature exposures for epidemiological studies. The novelty of some of the approaches Dr. Kloog uses lies in the ability to ensemble novel hybrid satellite-based GIS and geo-statistical methodologies extending the spatiotemporal scale dramatically compared to the state of the art.

Richard Kwok, PhD, is a Program Director for the Population Studies and Genetics Branch of the Division of Neuroscience at the National Institute on Aging. Dr. Kwok is an environmental epidemiologist with experience in multi-site epidemiologic studies of chronic disease outcomes across the life span. His interests span the environmental health sciences from exposure assessment and personal dosimetry to biomonitoring and the exposome as it applies to Alzheimer’s Disease and related dementias and its precursors across the life course. He is involved in a number of trans-NIH and interagency working groups on a range of topics including: large data harmonization and common data elements efforts; disasters and wildfires; and the All of Us Research Program. Prior to joining NIA, Dr. Kwok served in a variety of roles at NIEHS including staff scientist, program director, and acting Chief-of-Staff of the institute. His work has included research into disasters, air and water pollution, including heavy metals like arsenic, oil spill chemicals, particulate matter, and non-ionizing UV radiation exposures with outcomes including cancer, cardiovascular, mental health, neurologic, reproductive and respiratory health outcomes. Dr. Kwok received his BSPH in environmental science, and his MSPH and PhD in epidemiology from the University of North Carolina at Chapel Hill.

Jinkook Lee, PhD, is a Research Professor of Economics and Director of the Global Aging, Health, and Policy Program at the Center for Economic and Social Research, University of Southern California. She has spearheaded the development of large-scale, interdisciplinary population surveys, harmonized the data for cross-country and longitudinal analyses, and built accessible infrastructure for data sharing, such as the Gateway to Global Aging Data. She also leads the Gateway Exposome Coordinating Center, which promotes the interdisciplinary study of how environmental exposures over one’s life span influence cognitive health. Her pioneering work in Alzheimer’s Disease and Alzheimer’s Disease Related Dementias  (AD/ADRD) research includes developing the Harmonized Diagnostic Assessment of Dementia for the Longitudinal Aging Study in India(LASI-DAD) — which laid the groundwork for many cognitive aging and dementia studies, particularly in the Global South— as well as innovative research efforts that have deepened understanding of the complex interplay of AD/ADRD risk factors, ranging from biological markers to environmental exposome. She provides scientific advice for the World Health Organization, the Organisation for Economic Co-operation and Development, the United Nations, the World Bank, and the Asian Development Bank and serves on the editorial boards for several scientific journals. She received a Ph.D. from Ohio State University and a B.S. from Seoul National University and previously held a professorship at Ohio State University and the Pardee RAND Graduate School.

Yue Leng, PhD, is an Associate Professor of Psychiatry at the University of California, San Francisco (UCSF) and a Senior Atlantic Fellow at the Global Brain Health Institute. She holds an MPhil and PhD in Epidemiology from the University of Cambridge and completed her postdoctoral training at UCSF. Dr. Leng’s research focuses on elucidating the links between sleep, circadian rhythms, and the risk of Alzheimer’s and Parkinson’s disease, employing epidemiological methods alongside AI and big data analytics. Her research has been funded by NIH K99/R00, R21, and R01 awards and has received widespread media coverage.

Léa Maitre, PhD, is a tenure-track Assistant Research Professor at ISGlobal in Barcelona, where she leads research on the exposome across pregnancy, early life, and women’s health. Her work integrates epidemiology, biomarker discovery, and multi-omics to understand how chemical and biological exposures during sensitive developmental windows shape maternal and child health. She has contributed extensively to major exposome and birth cohort EU initiatives. Currently, she leads projects on the hormonal and chemical determinants of pregnancy and puberty biology, the exposomic basis of psychiatric disorders, microbiome-related mechanisms in neurotoxicity, and methodological development for the integration of untargeted exposomics and multi-omics data. Her research aims to translate exposomic science into mechanistic insight and better prediction of health trajectories across the life course. 

Carolyn J. Mattingly, PhD, is a Distinguished Professor at North Carolina State University (NC State) whose research integrates toxicogenomics, bioinformatics, and environmental health sciences to understand how environmental exposures influence human disease. Since 2001, she has helped develop and expand the Comparative Toxicogenomics Database (CTD; ctdbase.org), a publicly available resource that integrates curated literature-based information on interactions among chemicals, genes, phenotypes, diseases, and exposome-related data with computational tools that support discovery of environmentally influenced disease mechanisms. Her current research combines CTD-driven toxicogenomic analyses with zebrafish models to predict and experimentally validate exposure-related outcomes relevant to neurodegenerative diseases such as Alzheimer’s disease and Amyotrophic Lateral Sclerosis. Dr. Mattingly previously served as Head of the Department of Biological Sciences at NC State and as Director of NC State’s Superfund Research Program focused on per- and polyfluoroalkyl substances (PFAS). She is also a member of NC State’s Research Leadership Academy.

Gary W. Miller, PhD, is the Adrienne Block Professor of Environmental Health Sciences and Vice Dean for Research Strategy and Innovation at the Mailman School of Public Health, and Professor of Molecular Pharmacology and Therapeutics in the Vagelos College of Physicians and Surgeons. Dr. Miller also serves as the Director of the Center for Innovative Exposomics.  Dr. Miller began his work on the exposome in 2010. Since that time, he founded and directed the first NIH center on the exposome, authored the first book on the topic, and served as an advisor on several international projects. He is currently contact-MPI of NEXUS, the NIH-funded exposome coordinating center established in 2024, and Director of the ARPA-H-funded project IndiPHARM, which uses exposomics to improve drug effectiveness. From 2013 to 2019, Dr. Miller served as the Editor-in-Chief of Toxicological Sciences, the flagship journal of the Society of Toxicology, and is now Editor-in-Chief of Exposome, the first journal in the field. Dr. Miller is a member of the NIH All of Us Research Advisory Panel and an elected Fellow of the American Association for the Advancement of Science. 

Dr. Miller completed his PhD in Pharmacology and Toxicology from the University of Georgia and postdoctoral training in molecular neuroscience at Emory University and Duke University. From 1998 to 2002, he was a faculty member in the Division of Pharmacology and Toxicology at the University of Texas at Austin. Dr. Miller moved to Emory University in 2002. He served as Professor at the Department of Environmental Health in the Rollins School of Public Health and the Departments of Pharmacology and Neurology in the School of Medicine and Associate Dean for Research at Rollins School of Public Health from 2009 to 2018. From March to July of 2026, Dr. Miller is serving as an International Collen-Francqui Chair at Ghent University, Antwerp University, KU Leuven, Hasselt University, and the University of Liège in Belgium. 

R. Sean Morrison, MD, FAAHPM, is the Ellen and Howard C. Katz Professor and Chair of the Brookdale Department of Geriatrics and Palliative Medicine at the Icahn School of Medicine at Mount Sinai. He also serves as Director of the National Palliative Care Research Center and Co-Director of the Patty and Jay Baker National Palliative Care Center. A past president of the American Academy of Hospice and Palliative Medicine, Dr. Morrison is a national leader in aging and serious illness care. He has received over $75 million in research funding and published widely in top medical journals, including the New England Journal of Medicine, Annals of Internal Medicine, and the Journal of the American Medical Association. He has been on the faculty at Mount Sinai since 1995.

Shoji Nakayama, MD, PhD, is the Deputy Director of the Japan Environment and Children’s Study (JECS) Programme Office at the National Institute for Environmental Studies (NIES). He is a lead exposure scientist for JECS, a landmark longitudinal birth cohort study following 100,000 mothers and children. Dr. Nakayama’s research focuses on human biomonitoring and, most recently, the exposome. To advance children’s environmental health, he collaborates extensively with research institutions across the US, Canada, the EU, and Asia.

Previously, Dr. Nakayama spent six years as an invited researcher at the U.S. Environmental Protection Agency, investigating contaminants of emerging concern before returning to Japan to join NIES in 2011. He holds adjunct professorships at St. Luke’s International University and the University of Tsukuba, and is certified as a Public Health Specialist/Supervisor by the Japan Board of Public Health and Social Medicine. Additionally, he serves as an Associate Editor for Environment International and the Journal of Exposure Science and Environmental Epidemiology.

Brad A. Racette, MD, FAAN, is the Kemper and Ethel Marley Professor, Chair of Neurology, and Senior Vice President at Barrow Neurological Institute. He is also Professor and Academic Chair for Creighton University School of Medicine, Professor and Chair of the University of Arizona College of Medicine (Barrow Neurological Institute Campus), Professor of Translational Neurosciences for the University of Arizona College of Medicine, Professor Emeritus at Washington University School of Medicine, and Honorary Professor at the University of the Witwatersrand School of Public Health in Johannesburg, South Africa.

Dr. Racette earned his bachelor’s degree in molecular biology from Princeton University in New Jersey and his medical degree from the Feinberg School of Medicine at Northwestern University in Chicago. He completed his neurology residency and a fellowship in movement disorders at Washington University School of Medicine in St. Louis.

Dr. Racette’s clinical expertise includes the diagnosis and management of all types of movement disorders, and he was named to the Best Doctors list in St. Louis for 14 consecutive years before moving to Barrow Neurological Institute and  was named to 100 Best Doctors in Arizona in 2024.

Dr. Racette’s research focuses on identifying environmental risk factors for Parkinson’s disease and other neurodegenerative diseases. He has authored over 190 peer-reviewed publications and served on numerous international review committees and advisory boards.

Cécilia Samieri, DVM, PhD, is Director of Research at INSERM at the Bordeaux Populational Health Research Center, specializing in the epidemiology of brain aging. Her research aims at understanding the role of environmental factors (the exposome) in the onset of age-related brain diseases such as Alzheimer’s disease. Trained in veterinary medicine, Dr. Samieri turned to research and obtained a PhD in Epidemiology and Public Health from the University of Bordeaux in 2009. She continued her work as a postdoctoral fellow at the Channing Division of Network Medicine (Harvard Medical School and Harvard School of Public Health) in Boston. On her return to the laboratory in 2012, she obtained a researcher position with the support of the Alzheimer’s Foundation before joining INSERM in 2015. She was promoted to Research Director in 2021. By analyzing large samples of population-based cohort studies with comprehensive characterization of the exposome, leveraging molecular epidemiology and deep brain phenotyping, the aim of Dr. Samieri and her group is to identify the factors and mechanisms which, early in life, enable the brain to adapt to aging or, conversely, to lead to dementia. She has recently set up a new cohort, the B cube study, to investigate the exposome of brain aging and dementia in early stages. The aim is to define early prevention strategies that could delay or avoid the disease. Ultimately, the hope is to reduce the burden of this disease on society.

Nikolaos Scarmeas, MD, MS, PhD,  is Professor of Neurology at the Medical School of the National and Kapodistrian University of Athens, while he maintains an academic affiliation with Columbia University in New York. After earning his medical degree from the National and Kapodistrian University of Athens, he relocated to the United States to complete his residency in neurology at Columbia University Medical Center. While there, he also completed a two-year clinical fellowship in aging and dementia and earned a Master’s degree in Biostatistics and Epidemiology.

His research interests include cognitive reserve (i.e. how higher IQ, education, more demanding occupational attainments, or more engagement in cognitive-social-physical leisure – lifestyle activities can help the elderly cope better with the damage caused to their brains by Alzheimer’s disease and aging and therefore reduce their risk for dementia and slow down their rates of cognitive and functional decline). In addition, he has extensively investigated the contribution of diet (in particular composite dietary patterns such as a Mediterranean-type diet and others) in relation to dementias, Alzheimer’s disease, cognitive decline, and other aspects of aging. His work has been funded by the NIH-NIA and the Alzheimer’s Association, and he regularly reviews for major international journals and global funding agencies, including the NIH and European Union.

Emma Schymanski, Dr. rer. nat., is head of the Environmental Cheminformatics (ECI) group at the Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, where she is an FNR ATTRACT Fellow and special advisor to the rector for Open Science and Research Data Management. She served as Deputy Director of LCSB in 2024/5 (1 year mandate). She has a double degree in Chemistry/Environmental Engineering from UWA, Perth and completed her PhD at UFZ Leipzig and postdoc at Eawag, Switzerland. Her research combines cheminformatics and computational (high resolution) mass spectrometry approaches to elucidate the unknowns in complex samples, primarily with non-target screening, and relate these to environmental causes of disease. She is involved in many collaborative efforts, with >18,000 citations, >130 publications, and a book. An advocate for FAIR and open science, she is involved in several European and worldwide activities to improve the exchange of data, information and ideas between scientists, including the NORMAN Suspect List Exchange, MassBank, MetFrag, PubChemLite for Exposomics, PubChem PFAS Tree, patRoon, ShinyTPs, and Chemical Stripes.

Rémy Slama, PhD is a researcher in environmental health working as a senior investigator at INSERM and as Professor (Professeur attaché) at ENS-PSL (Ecole Normale Supérieure), Paris. His current research addresses the optimization of climate change mitigation strategies to maximize health co-benefits and limit inequalities. It is developed at IBENS, a joint research unit from INSERM, CNRS and ENS-PSL. Formerly, his work dealt with the effects of atmospheric pollutants, endocrine disruptors, and the exposome as a whole, as well as on related methodological issues. He coordinated the Observatory of Fecundity in France and the SEPAGES exposome cohort, funded by the ERC, co-authoring more than 250 articles and a dozen book chapters and books. He received his PhD in epidemiology from University Paris-Sud and degrees from Ecole Polytechnique and AgroParisTech (life sciences). He is a recipient of ISEE Tony McMichael mid-career award.He formerly held the annual chair in public health at the Collège de France (2022) and was head of Inserm Public Health Institute (2020-2024). He developed and led the Inserm-Grenoble Alps University research team in environmental epidemiology (2008-2024) where he launched SEPAGES exposome couple-child cohort and participated in several EU projects such as Athlete and Helix exposome projects. He has participated in several expert committees in environmental health at the national level (e.g. as head of the scientific council of the national research plan on endocrine disruptors or member of the scientific council of Public Health France), EU (SCHEER, Scientific Committee on Health, Environmental and Emerging Risks) and international levels, representing the International Society of Environmental Epidemiology at the World Health Assembly. He is a member of French national ethical committee (CCNE) and of the Group of Chief Scientific Advisors of the European Commission.

Martha M. (Mara) Téllez Rojo, MSc, DSc, is a Professor at the National Institute of Public Health in Mexico and a member of the National Academy of Medicine. She is Co-Principal Investigator and founder of the ELEMENT (2002) and PROGRESS (2007) birth cohorts, which examine the long-term effects of environmental exposures, social stressors, and lifestyle factors across the life course. She led the development of a population biomonitoring system that informed national lead control policy in Mexico and has served as a model for low- and middle-income countries. In Latin America, she promotes biomonitoring as a tool to address environmental health challenges.  In collaboration with Drs. Elizabeth Roberts and Anita Hardon, she has also introduced the novel concept of Anthroposomics.

Rodolphe Thiébaut, MD, PhD,  is professor of Public Health and Biostatistics at the University of Bordeaux and adjunct professor at McGill University (Department of Epidemiology, Biostatistics and Occupational Health). He leads the Inserm U1219 Bordeaux Population Health research centre, in which he has created the research group SISTM (Statistics in Systems Biology and Translational Medicine) devoted to data science in immunology. This group has been recognized as an INRIA project team since January 2015.

He is leading the Department of Medical Information of the Bordeaux Hospital in charge of the methodological support of the clinical research at the hospital as well as the organisation and the analysis of medical information including the Clinical Data Warehouse. Since 2018, he has led the Graduate’s program Digital Public Health that includes a Master in Public Health Data Science, a dual degree program with McGill University.

Mireia Valles-Colomer, PhD, is a tenure-track Principal Investigator in the Department of  Medicine and Life Sciences (MELIS) at the University Pompeu Fabra in Barcelona, Spain, where she is leading the Microbiome Research Group. Her research focuses on elucidating the link between the gut microbiome and mental health at the population level, along with its social transmission.

With a background in Microbiology and Computational Biology (Autonomous University of Barcelona, Spain and Free University of Brussels, Belgium), her research focuses on the role of the human microbiome in mental health and its transmission among individuals. She performed the first population-level study on the link between the gut microbiome and host anxiety and depression during her PhD at the Raes Lab at VIB-KU Leuven (Belgium), in which she characterized the microbial production and degradation of neuroactive compounds in metagenomic data (Valles-Colomer et al, Nat. Microbiology 2019). The study was included in “Nature milestones 2019” as milestone paper in human microbiota research. During her postdoc (EMBO long-term fellowship, Segata lab at the University of Trento, Italy) she also showed that the gut microbiome can be transmitted among multiple familial generations (Valles-Colomer et al, Nat. Microbiology 2022), and performed the first large-scale study on the person-to-person transmission landscape of the gut and oral microbiomes (Valles-Colomer et al, Nature 2023).

Roel Vermeulen, PhD, is Professor of Environmental Epidemiology and Exposome Science at Utrecht University and University Medical Center Utrecht (UMCU). He is a Distinguished University Professor for his interdisciplinary leadership and scientific excellence. His research focuses on the environmental causes of non-communicable diseases, combining exposure science, epidemiology and molecular biology. He is internationally recognized for advancing exposome research, coordinating major initiatives such as the Dutch Exposome-NL Gravitation Programme, the EU-funded EXPANSE project (part of the European Human Exposome Network), the International Human Exposome Network (IHEN) and the AURORA project on micro- and nanoplastics.

Prof. Vermeulen is Scientific Director of the Institute for Preventive Health (i4PH), a strategic alliance between Eindhoven University of Technology, Wageningen University & Research, Utrecht University, and UMC Utrecht. He chairs the Planetary Health Community within Utrecht Life Sciences and is a visiting professor at Imperial College London. He previously worked at the U.S. National Cancer Institute.

Prof. Vermeulen has over 900 peer-reviewed publications and is a widely cited expert in environmental health and has contributed to international policymaking through advisory roles with the WHO, the U.S. National Toxicology Program and the Dutch Health Council.

Rick Woychik, PhD, currently serves as Senior Advisor to the NIH Director. Previously, he was the Director of the National Institute of Environmental Health Sciences and the National Toxicology Program from June 2020 until October 2025 and Deputy Director since 2011. He is a molecular geneticist with a PhD in molecular biology from Case Western Reserve University and postdoctoral training with Dr. Philip Leder at Harvard Medical School. He spent almost 10 years at Oak Ridge National Laboratory, rising in the ranks to become head of the Mammalian Genetics Section and then director of the Office of Functional Genomics. In August 1997, he assumed the role of vice chairman for research and professor in the Department of Pediatrics at Case Western Reserve University. In 1998, he moved to the San Francisco Bay area, first as the head of the Parke-Davis Laboratory for Molecular Genetics and then as chief scientific officer at Lynx Therapeutics. He returned to academics as the president and CEO of The Jackson Laboratory in August 2002 and served in that role until January 2011.

Robert Wright, MD, MPH, is a pediatrician, medical toxicologist, and environmental epidemiologist at the Icahn School of Medicine at Mount Sinai. He is the Ethel H. Wise Chair of the Department of Environmental Medicine, Co-Director of the Institute for Exposomic Research, and Principal Investigator of an ongoing longitudinal birth cohort in Mexico City (Programming Research in Obesity, Growth, Environment and Social Stress–PROGRESS) in collaboration with the National Institute of Public Health, Mexico. He also founded the MATCH (Metals Assessment Targeting Community Health) study in Tar Creek, Oklahoma. Dr. Wright studies exposomics, chemical mixtures, epigenetics and the role of social stressors as modifiers of chemical toxicity. He has published over 500 research studies and has served on numerous international and national committees and advisory boards. Dr. Wright founded the Senator Frank Lautenberg Laboratory of Environmental Health Sciences at Mount Sinai in 2014 and in 2022 launched the “Exposomic in Precision Medicine” program as part of Mount Sinai’s Clinical and Translational Science Awards (CTSA) Program. The program is designed to make the environment an integral part of precision medicine initiatives with the goal of bringing it into clinical training as a tool for optimally determining treatment options and variable individual responses to treatment.